FADS2 and urinary bladder carcinoma: To corroborate these findings, immunohistochemical staining of FADS2 was performed on pathological slices obtained from patients with bladder cancer at our centre, which confirmed the elevated expression of FADS2 in bladder cancer tissues (Figure 1D).